Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Recombinant Human IL-15 in CREATE Workflows
2026-09-29
Recombinant Human IL-15 provides a defined cytokine-support layer for primary T-cell recovery, expansion, and functional testing around RNA-based CREATE editing experiments. This guide connects IL-15 dose finding with controls that distinguish cell-state effects from genuine genomic insertion outcomes.
-
Verapamil HCl: A Transporter-Aware Research Tool
2026-09-29
Verapamil HCl is more than an L-type calcium channel blocker: in drug-sensitive cancer assays, it can also expose transporter-dependent changes in intracellular compound exposure. This article translates that insight into better calcium-signaling, apoptosis, myeloma, and inflammation study designs.
-
Fingolimod (FTY720) as a T-Cell Trafficking Probe
2026-09-28
Fingolimod (FTY720) offers more than established multiple sclerosis biology: it can serve as a mechanistic perturbation tool for separating lymphocyte availability from tumor-directed migration. This article explains how to use its S1P biology to interpret magnetic CAR-T-mimicking cell assays without overstating combination evidence.
-
ML365: From TASK1 Currents to Translational Questions
2026-09-28
ML365 connects selective TASK1 channel inhibition with an emerging neuroinflammation use case. Explore the mechanistic rationale, aged-mouse findings, experimental controls, and translational limits that matter when moving from ion-current data to biological interpretation.
-
BML-277: Chk2 Signaling Beyond the Checkpoint
2026-09-27
Chk2 inhibition is a way to probe more than canonical DNA-damage checkpoints. This article connects BML-277’s experimental profile with emerging evidence on nuclear cGAS, while distinguishing established findings from translational hypotheses and offering a practical framework for study design.
-
Carbenoxolone disodium: Practical Research Guide
2026-09-26
Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access and gap junction communication. Use it with matched-vehicle, viability, and orthogonal pathway controls; it is not a selective target-validation reagent or an established in vivo efficacy treatment.
-
PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis
2026-09-25
A metabolomic comparison of PEDV-infected porcine and primate cells identified cell-specific changes in purine metabolism, while genetic and pharmacological experiments implicated IMPDH-dependent guanine nucleotide synthesis in viral replication. The findings support IMPDH as a host-directed antiviral target, but remain preclinical and do not establish efficacy in infected pigs.
-
Stiripentol Workflows for LDH and Lactate Research
2026-09-25
Use Stiripentol to probe LDH-dependent lactate metabolism with a workflow that separates direct enzyme effects from downstream changes in histone lactylation and immune-cell behavior. The article translates a recent colorectal cancer study into cautious, testable assay choices without implying that Stiripentol has been validated as a tumor-immunotherapy intervention.
-
RIPA Lysis Buffer (Medium) for EV Signaling
2026-09-24
Turn MRSA extracellular-vesicle stimulation into pathway-resolved protein data with a practical workflow for cell and tissue lysates. Learn where RIPA Lysis Buffer (Medium) supports Western blots and where its detergent strength calls for a different approach, especially in complex-preserving assays.
-
Solanesol (B8776): Practical Handling and QC
2026-09-24
Solanesol provides a research-grade polyisoprenoid alcohol for workflows that need a hydrophobic compound in membrane-related biochemical studies, including apoptosis research and metabolic enzyme assays. It dissolves in DMSO at the stated product-dossier concentration but is insoluble in water and ethanol, so it is not suited to direct aqueous or ethanol-based preparation.
-
G418 Sulfate for Stable Cell Selection Workflows
2026-09-23
Geneticin supports stable-cell workflows when an engineered construct carries a neomycin-resistance gene—and only after a cell-specific kill curve establishes a useful selection window. This guide connects that practical use to an engineered pheochromocytoma model, while distinguishing antibiotic selection from the model’s separate therapeutic experiments and from exploratory Dengue virus research.
-
CSBTA Pharmacokinetics in MASH: Study Insights
2026-09-23
The reference study integrates plasma pharmacokinetics, tissue distribution, hepatocyte accumulation, transporter assays, and metabolic-enzyme analysis to explain why Corydalis saxicola Bunting total alkaloids behave differently in MASH-model mice. Its findings show that disease state and repeated dosing can increase exposure to key alkaloids, highlighting the need for disease-informed dose evaluation rather than direct extrapolation from healthy animals.
-
BIIE 0246: Y2R Antagonist Workflow Guide
2026-09-22
BIIE 0246 enables selective interrogation of neuropeptide Y Y2 receptor signaling across synaptic, metabolic, gastrointestinal, and behavioral assays. This practical guide shows how to use it as a mechanistic control while avoiding a critical interpretive error: the featured cardiac study implicates Y1R, not Y2R, as the direct arrhythmogenic receptor.
-
Heparin Sodium as an HSPG Assay Probe
2026-09-22
Heparin sodium is more than a coagulation reagent: it can help researchers interrogate heparan sulfate proteoglycan-dependent nanovesicle uptake. This guide connects anticoagulation readouts with the mechanistic findings of a recent Sertoli-cell study while clearly separating evidence from experimental recommendations.
-
BML-277 and the Nuclear Chk2–cGAS Checkpoint
2026-09-21
BML-277 offers a precise way to interrogate Chk2-dependent DNA damage signaling, from T-cell radioprotection to genome integrity. This thought-leadership perspective connects its biochemical profile with emerging evidence that Chk2 phosphorylates nuclear cGAS to regulate TRIM41-mediated degradation of the LINE-1 protein ORF2p.